The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
2022 · Cancer Communications · 168 citations
https://doi.org/10.1002/cac2.12274
M
Midie Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
186
Papers
4.4K
Citations
34
h-index
76
i10-index
Midie Xu is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & Ferroptosis and cancer prognosis. The author has an h-index of 34, co-authored 159 publications.
Papers by this author
worksThe polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
2018 · Journal of Hematology & Oncology · 129 citations
https://doi.org/10.1186/s13045-017-0547-3
Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
2021 · Journal of Experimental & Clinical Cancer Research · 84 citations
https://doi.org/10.1186/s13046-021-02143-x
<p>Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases</p>
2019 · Cancer Management and Research · 42 citations
https://doi.org/10.2147/cmar.s196919
Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer
2020 · Cell Biology and Toxicology · 38 citations
https://doi.org/10.1007/s10565-020-09525-5
Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials
2019 · Oncology Research and Treatment · 36 citations
https://doi.org/10.1159/000500204
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat